Should we stop using electroconvulsive therapy?
BMJ 2019; 364 doi: https://doi.org/10.1136/bmj.k5233 (Published 30 January 2019) Cite this as: BMJ 2019;364:k5233- John Read, professor of clinical psychology1,
- Sue Cunliffe, electroshock survivor,
- Sameer Jauhar, senior research fellow2,
- Declan M McLoughlin, professor3
- 1University of East London, London, UK
- 2Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King’s College, London, UK
- 3Department of Psychiatry, Trinity College Dublin, St Patrick’s University Hospital, Dublin, Ireland
- Correspondence to: J Read john{at}uel.ac.uk, D M McLoughlin d.mcloughlin{at}tcd.ie
Yes—John Read and Sue Cunliffe
Electroconvulsive therapy (ECT) was first administered in 1938. The first study, in 1951, showed that people who had had ECT fared worse than those who hadn’t.1
Today, positive, evidence based, risk-benefit analyses are required for treatments. However, systematic23 and narrative4 reviews (by JR and colleagues) identify only 10 studies comparing ECT with placebo for depression (placebo includes general anaesthetic but no shock). Half found no difference. The other five found a temporary lift in mood, but only during the treatment period, and in about only a third of patients. In the famous Northwick Park study5 this minimal improvement was perceived only by psychiatrists, not by nurses or patients.
The many reviews and meta-analyses claiming that ECT works67 do so purely on the basis of these temporary gains, in a minority of patients, found in just half the studies. Furthermore, none of them identify any placebo controlled studies showing that ECT reduces depression beyond treatment or prevents suicide.234
Despite this lack of evidence psychiatry remains so adamant ECT works that no studies to establish efficacy have been conducted since 1985.234 Instead, many studies investigate which kind of ECT causes least damage.2
Memory loss and brain damage
Brain cells receive electrical signals of a fraction of one volt. Subjecting them to 150 V inevitably causes damage, similar to traumatic brain injury.8 Early post-mortem examinations led to the article “Brain damaging therapeutics,” in which the …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £184 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£50 / $60/ €56 (excludes VAT)
You can download a PDF version for your personal record.